Wilson's disease: Difference between revisions

 
(5 intermediate revisions by the same user not shown)
Line 6: Line 6:
==Clinical Features==
==Clinical Features==
[[File:PMC4357635 jbm-22-33-g004.png|thumb|Under slit-lamp test, Kayser-Fleischer ring is evident around the border of cornea (arrow).]]
[[File:PMC4357635 jbm-22-33-g004.png|thumb|Under slit-lamp test, Kayser-Fleischer ring is evident around the border of cornea (arrow).]]
[[File:Kayser-Fleischer ringArrow.jpg|thumb|Another example of Kayser–Fleischer ring (brown ring on the edge of the iris).]]
[[File:KF ring 2.jpg|thumb|Copper deposition on corneal Descemet's membrane on slit lamp exam.]]
*Hepatic  
*Hepatic  
**Kayser-Fleischer rings (highly specific)
**Kayser-Fleischer rings (highly specific)
Line 22: Line 24:


==Differential Diagnosis==
==Differential Diagnosis==
===Hepatic dysfunction===
{{Hepatomegaly DDX}}
'''Infectious'''
*[[Hepatitis]]
*[[Malaria]]
*[[HIV]] (present in 50% of AIDS patients)<ref>Tintanelli's</ref>
*[[EBV]]
*[[Babesiosis]], [[leptospirosis]]
*[[Typhoid]]
*[[Hepatic abscess]], [[amebiasis]]
'''Neoplastic'''
*Metastases
*[[Hepatocellular carcinoma]]
*[[Multiple myeloma]]
*[[Leukemia]]
*[[Lymphoma]]
*[[Myeloproliferative disorders]]
'''Metabolic'''
*[[Hemochromatosis]]
*[[Wilson's disease]]
*[[Non-alcoholic steatohepatitis]]
*[[Inborn errors of metabolism]]
'''Biliary'''
*Biliary cirrhosis
'''Drugs'''
*Alcoholic [[cirrhosis]]
*[[Alcoholic hepatitis]]
*[[Hepatotoxicity|Hepatotoxic drugs]]
''Miscellaneous''
*Veno-occlusive disease
*[[CHF]] (right heart failure)


===Neuro/psychiatric symptoms===
===Neuro/psychiatric symptoms===
Line 59: Line 32:
*Primary psychiatric disorder (e.g. [[depression]], [[bipolar disorder]], [[schizophrenia]]
*Primary psychiatric disorder (e.g. [[depression]], [[bipolar disorder]], [[schizophrenia]]
*[[Dementia]]
*[[Dementia]]
*Drug abuse  
*Drug abuse
 


==Evaluation==
==Evaluation==
===Workup===
*[[LFTs]] to assess ALT/AST
*[[LFTs]] to assess ALT/AST
*CBC to assess for anemia (followed by testing for Coombs-negative hemolytic anemia)
*CBC to assess for anemia (followed by testing for Coombs-negative hemolytic anemia)
*Ocular slit-lamp to assess for Kayser-Flesicher rings  
*Ocular slit-lamp to assess for Kayser-Flesicher rings  
===Diagnosis===
*Outpatient ceruloplasmin concentration, serums copper concentration, 24-hour urinary copper excretion +/- genetic testing can be done to confirm diagnosis
*Outpatient ceruloplasmin concentration, serums copper concentration, 24-hour urinary copper excretion +/- genetic testing can be done to confirm diagnosis
*Hepatology consult should be made for follow up


==Management==
==Management==
*Potent chelators: D-penicillamine (first-line), trientine (second-line), oral zinc  
*Potent chelators: D-penicillamine (first-line), trientine (second-line), oral zinc  
*Low-copper diet  
*Low-copper diet  
*Screening for hepatocellular carcinoma (HCC) recommended but unclear association


==Disposition==
*Hepatology consult should be made for follow up
**Screening for hepatocellular carcinoma (HCC) recommended but unclear association
==See Also==
==External Links==


==References==
==References==
1. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184:173.
#Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184:173.
2. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28 Suppl 1:28.
#Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28 Suppl 1:28.
3. Soltanzadeh A, Soltanzadeh P, Nafissi S, et al. Wilson's disease: a great masquerader. Eur Neurol 2007; 57:80.
#Soltanzadeh A, Soltanzadeh P, Nafissi S, et al. Wilson's disease: a great masquerader. Eur Neurol 2007; 57:80.
4. Stremmel W, Meyerrose KW, Niederau C, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115:720.
#Stremmel W, Meyerrose KW, Niederau C, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115:720.
 
[[Category:GI]]

Latest revision as of 20:54, 7 September 2022

Background

  • Autosomal recessive
  • Impairment of biliary cellular copper excretion with accumulation in organs (mostly liver, brain, cornea)
  • Liver becomes cirrhotic with ~5% developing liver failure

Clinical Features

Under slit-lamp test, Kayser-Fleischer ring is evident around the border of cornea (arrow).
Another example of Kayser–Fleischer ring (brown ring on the edge of the iris).
Copper deposition on corneal Descemet's membrane on slit lamp exam.

Differential Diagnosis

Hepatic Dysfunction

Infectious

Neoplastic

Metabolic

Biliary

  • Biliary cirrhosis

Drugs

Miscellaneous

Neuro/psychiatric symptoms

Evaluation

Workup

  • LFTs to assess ALT/AST
  • CBC to assess for anemia (followed by testing for Coombs-negative hemolytic anemia)
  • Ocular slit-lamp to assess for Kayser-Flesicher rings

Diagnosis

  • Outpatient ceruloplasmin concentration, serums copper concentration, 24-hour urinary copper excretion +/- genetic testing can be done to confirm diagnosis

Management

  • Potent chelators: D-penicillamine (first-line), trientine (second-line), oral zinc
  • Low-copper diet

Disposition

  • Hepatology consult should be made for follow up
    • Screening for hepatocellular carcinoma (HCC) recommended but unclear association

See Also

External Links

References

  1. Lorincz MT. Neurologic Wilson's disease. Ann N Y Acad Sci 2010; 1184:173.
  2. Gollan JL, Gollan TJ. Wilson disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28 Suppl 1:28.
  3. Soltanzadeh A, Soltanzadeh P, Nafissi S, et al. Wilson's disease: a great masquerader. Eur Neurol 2007; 57:80.
  4. Stremmel W, Meyerrose KW, Niederau C, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115:720.
  1. Tintanelli's